Arts HJ - Search Results

1

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V. van Dam GM, et al. Among authors: arts hj. Nat Med. 2011 Sep 18;17(10):1315-9. doi: 10.1038/nm.2472. Nat Med. 2011. PMID: 21926976

2

Laparoscopic placement of PAP catheters for intraperitoneal chemotherapy in ovarian carcinoma.

Arts HJ, Willemse PH, Tinga DJ, de Vries EG, van der Zee AG. Arts HJ, et al. Gynecol Oncol. 1998 Apr;69(1):32-5. doi: 10.1006/gyno.1998.4968. Gynecol Oncol. 1998. PMID: 9570995

3

Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis.

Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, Kampinga HH, Van der Zee AG. Arts HJ, et al. Int J Cancer. 1999 Jun 21;84(3):234-8. doi: 10.1002/(sici)1097-0215(19990621)84:3<234::aid-ijc6>3.0.co;2-9. Int J Cancer. 1999. PMID: 10371339

4

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.

Arts HJ, Katsaros D, de Vries EG, Massobrio M, Genta F, Danese S, Arisio R, Scheper RJ, Kool M, Scheffer GL, Willemse PH, van der Zee AG, Suurmeijer AJ. Arts HJ, et al. Clin Cancer Res. 1999 Oct;5(10):2798-805. Clin Cancer Res. 1999. PMID: 10537344

5

Options for modulation of drug resistance in ovarian cancer.

Arts HJ, Van Der Zee AG, De Jong S, De Vries EG. Arts HJ, et al. Int J Gynecol Cancer. 2000 Jan;10(S1):47-52. doi: 10.1046/j.1525-1438.2000.99511.x. Int J Gynecol Cancer. 2000. PMID: 11240733

6

Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.

Arts HJ, de Jong S, Hollema H, ten Hoor K, van der Zee AG, de Vries EG. Arts HJ, et al. Gynecol Oncol. 2004 Mar;92(3):794-800. doi: 10.1016/j.ygyno.2003.11.054. Gynecol Oncol. 2004. PMID: 14984943

7

Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors.

Arts HJ, de Jong S, Hollema H, Ten Hoor KA, de Vries EG, van der Zee AG. Arts HJ, et al. Int J Oncol. 2005 Feb;26(2):379-84. Int J Oncol. 2005. PMID: 15645122

8

The prognostic value of TRAIL and its death receptors in cervical cancer.

Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG, de Bock GH, van der Zee AG. Maduro JH, et al. Among authors: arts hj. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):203-11. doi: 10.1016/j.ijrobp.2009.03.071. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695437

9

Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.

Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG. Noordhuis MG, et al. Among authors: arts hj. Clin Cancer Res. 2009 Dec 1;15(23):7389-97. doi: 10.1158/1078-0432.CCR-09-1149. Epub 2009 Nov 17. Clin Cancer Res. 2009. PMID: 19920104

10

Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial.

Mourits MJ, Bijen CB, Arts HJ, ter Brugge HG, van der Sijde R, Paulsen L, Wijma J, Bongers MY, Post WJ, van der Zee AG, de Bock GH. Mourits MJ, et al. Among authors: arts hj. Lancet Oncol. 2010 Aug;11(8):763-71. doi: 10.1016/S1470-2045(10)70143-1. Epub 2010 Jul 16. Lancet Oncol. 2010. PMID: 20638901 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters